The 4th Call for Proposals of the EuroNanomed initiative is launched on December 10th 2012.

Through 3 successful Joint Transnational Calls launched from 2009 to 2011, the EuroNanoMed ERA-NET initiative has allocated € 25 Million to transnational research projects in Nanomedicine.
The ERA-NET EuroNanoMed II launches a fourth Joint Call for Proposals to support transnational innovative research projects in Nanomedicine. Sixteen countries / regions are participating to this call for proposals: Belgium/Flanders, Belgium/Wallonia, France, Germany, Iceland, Israel, Italy, Latvia, Lithuania, Norway, Poland, Portugal, Romania, Spain, Sweden and Switzerland.

Electronic submission website:

  • Research project consortia who intend to submit a transnational proposal should register from January 14th 2013, at, by clicking on “to register” and following instructions.
  • Registration and electronic proposal submission must be completed before Monday 4th March 2013 17:00:00 CET.

Contact person for the Joint Call Secretariat

Veneto Nanotech S.C.P.A.
+39 049 7705520
Call related documents:
Checklist for the Coordinator
Call text
Proposal submission form
Guidelines for applicants
JTC 2013 Pre-eligiblity check Form for ITALIAN RESEARCHERS
AIMs of the call:
The aims of the call are:
  • To support translational research proposals that combine innovative approaches (basic, clinical, industrial ) in the field of Nanomedicine and;
  • To encourage and enable transnational collaboration between public and private research groups from academia (research teams from universities, higher education institutions, public research institutions) and clinical/public health research (research teams from hospital/ public health, healthcare settings and other healthcare organizations) or research teams from industrial enterprises (all size). The participation of SMEs is encouraged.

TOPICS of the call:

Project proposals will address multidisciplinary and translational research. The project proposals must cover at least one of the following areas that are equal in relevance for this call:

  • Regenerative medicine
  • Diagnostics
  • Targeted delivery systems

General conditions for application:

A consortium applying to this call must include research group(s) from at least two out of the three following categories, if eligible according to relevant national/regional funding organisation’s regulations for research funding:

  • academia (research teams working in universities, other higher education institutions or research institutes);
  • clinical/public health research sector (research teams working in hospitals/public health and/or other health care settings and health organizations);
  • enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) is encouraged.

Please note! Whilst applications will be submitted jointly by groups from several countries, individual groups will be funded by the individual EuroNanoMed II funding organization respective of the country/region from which applicants have applied. The applications are therefore subjected to eligibility criteria of individual funding organizations. Please note that the national eligibility conditions have evolved since the last EuroNanoMed call. Applicants are therefore strongly advised to contact their national representative as soon as possible in order to confirm their eligibility with their respective funding organizations.

Only transnational projects will be funded. Each proposal must involve a minimum of three research groups from three different countries including at least two EuroNanoMed II country/regions participating in the 4th joint transnational call. The maximum number of partners in a given consortium is seven. Research groups from countries whose funding organisations are not partners in this EuroNanoMed II call may participate in projects if they are able to secure their own funding.

Contact Point list:

Party n°

Participant organisation name


Contact details


Agence Nationale de la Recherche (ANR)


Mariana Lassalle (+33) 1 73 54 81 93

Natalia Martin (+33) 1 73 54 81 33


Agentschap voor Innovatie door Wetenschap en Technologie (IWT)


Dirk Veelaert: (+32) 2 432 42 19


Service Public De Wallonie (SPW-DGO6)


Nicolas Delsaux (+32) 81 33 45 20


Vdi Technologiezentrum Gmbh (VDI)


Olaf Rotthaus (+49) 2 116214 – 233


The Icelandic Centre For Research (RANNIS)


Katrín Valgeirsdóttir (+354) 8684743


Chief Scientist Office, Ministry Of Health (CSO-MOH)


Benny Leshem (+972) (0) 2 5681209


Ministero Della Salute (IMH)


  Dr. Gaetano Guglielmi


Latvijas Zinatnu Akademija (LAS)


Yuri Dekhtyar (+371) 670 89 383


Lietuvos mokslo taryba (RCL)


Julija Sabataityte (+370) 5 261 9068


Norges Forskningsrad (RCN)


Cecilie Anita Mathiesen


Narodowe Centrum Badan i Rozwoju (NCBR)


Aleksandra Mościcka-Studzińska

(+48) 22 39 07 131


Fundação Para A Ciência E A Tecnologia (FCT)


Cristiana Leandro (+351) 213924 381


Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)


Mihaela Manole  (+40) 21 3023863


Instituto De Salud Carlos III (ISCIII)


Ignacio Baanante (+34) 9182 22576


Vetenskapsradet – Swedish Research Council(SRC)


Johan Nilsson (+46) 8 546 44 202


Schweizerischer Nationalfonds zur Förderung der wissenschaftlichen Forschung (SNSF)


Christoph Meier (+41) 31 308 23 62

Call documents





EuroNanoMed I & II call statistics

EuroNanoMed I & II call statistics

During the period 2009-2013, the ERA-NET EuroNanoMed I & II has successfully launched 4 joint calls for proposals.

The first 4 calls for proposals funded 31 transnational research projects on nanomedicine involving 165 partners from 21 countries/regions participating in the calls, with about € 32 million funding from the EuroNanoMed funding agencies and a further € 24 million funding from the research partners participating in the funded projects.

Country of origin of the applicants

Altogether, 648 partners from more than 21 countries participated in these calls, in a total of 141 submitted projects. As presented in figure 1, the number of applicants per country has globally grown between 2009 and 2013, as well as the number of submitted proposals (24 and 43 respectively).

2013 pirmas Figure 1: Number of applicants per country for the first 4 calls for proposals.

*NPC (Non participating country) refers to applicants that belonged to countries where no funding organization participated in the joint transnational call.

Overview of the 4 calls

The table below summarizes the outcomes of the first 4 calls for proposals:

2013 antras

Participation of research organizations in translational projects in Nanomedicine

As EuroNanoMed I & II joint calls for proposals aimed at funding translational research projects in Nanomedicine, each consortium had to include teams from at least 2 of the following categories: academia, clinic/public health, industry. The distribution between these three categories among consortia funded in the 4 calls is outlined in Figure 2. Noteworthy, 61% of the funded projects included partners from all three categories, indicating the high added value of these collaborations in nanomedicine translational research.

2013 trecias

Figure 2: Type of research organizations funded through the four EuroNanoMed I & II joint calls for proposals.

Scientific / technological areas covered by funded projects

The first 4 calls for proposals were open to projects covering at least one of the three priority topics of the European Technology Platform Nanomedecine: Targeted delivery systems, Diagnostics, Regenerative medicine. The coverage of these three scientific areas among funded projects is presented in figure 3.

2013 ketvirtas

Figure 3: Distribution of scientific areas covered by funded projects in the first 4 calls for proposals.